Vilex Revenue and Competitors
Estimated Revenue & Valuation
- Vilex's estimated annual revenue is currently $18.6M per year.
- Vilex's estimated revenue per employee is $251,000
Employee Data
- Vilex has 74 Employees.
- Vilex grew their employee count by 30% last year.
Vilex's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Founder | Reveal Email/Phone |
3 | VP Sales and Education | Reveal Email/Phone |
4 | VP, Medical Education & Marketing Communications | Reveal Email/Phone |
5 | VP Research And Development | Reveal Email/Phone |
6 | Director Marketing | Reveal Email/Phone |
7 | Consignment Specialist / Inventory Manager | Reveal Email/Phone |
8 | Buyer/Planner | Reveal Email/Phone |
Vilex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12M | 48 | 0% | N/A | N/A |
#2 | $8.3M | 33 | 3% | N/A | N/A |
#3 | $1.8M | 7 | -22% | N/A | N/A |
#4 | $8M | 32 | -9% | N/A | N/A |
#5 | $34.9M | 139 | -20% | N/A | N/A |
#6 | $24.6M | 98 | 7% | N/A | N/A |
#7 | $30.4M | 121 | 1% | N/A | N/A |
#8 | $15.1M | 60 | 9% | N/A | N/A |
#9 | $23.8M | 95 | 12% | N/A | N/A |
#10 | $8.5M | 34 | 31% | N/A | N/A |
What Is Vilex?
Vilex is an extremity medical device manufacturer for orthopedic and podiatric bone surgery. Vilex® offers a broad range of cannulated screws, FUZE TTC arthrodesis nail, HammerFUZE Compression System, AVID locking plates, small joint implants, NITINEX Staple System, Talex and TOV subtalar implants, and ring and rail external fixation devices. Vilex Internal and External Fixation products are manufactured in the USA. Vilex® markets its products primarily through independent sales representatives.
keywords:N/AN/A
Total Funding
74
Number of Employees
$18.6M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 77 | 22% | N/A |
#2 | N/A | 83 | 8% | N/A |
#3 | $23.8M | 88 | 7% | N/A |
#4 | $23.8M | 88 | 9% | N/A |
#5 | $25.8M | 89 | 3% | N/A |